Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
27.33
-2.50 (-8.38%)
At close: Oct 1, 2026, 4:00 PM EDT
26.79
-0.54 (-1.98%)
After-hours: Oct 1, 2026, 7:40 PM EDT
Biodesix Market Cap
Biodesix has a market cap or net worth of $288.36 million as of October 1, 2026. Its market cap has increased by 389.66% in one year.
Market Cap
288.36M
Enterprise Value
330.16M
1-Year Change
389.66%
Ranking
Category
Stock Price
$27.33
ChartMarket Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $288.36M, a decrease of -14.26%. That is a compound annual growth rate of -2.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 288.36M | 433.03% |
| Dec 31, 2025 | 54.10M | -75.69% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Personalis | 1.74B |
| Freenome | 1.71B |
| OPKO Health | 1.18B |
| Castle Biosciences | 1.11B |
| Fulgent Genetics | 599.15M |
| Myriad Genetics | 407.95M |
| Exagen | 196.47M |
| Burning Rock Biotech | 189.57M |